Targeting the PI3K Akt signaling pathway in pancreatic $\beta$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes

Sheila Donnelly

Targeting the PI3K Akt signaling pathway in pancreatic $\beta$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes

Sheila Donnelly

Infectious Disease

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

Original language	English (Ireland)
Number of pages	13
Journal	Journal of Diabetes
Volume	14
Issue number	4
Publication status	Published - 1 Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Camaya, Inah and Donnelly, Sheila and O'Brien, Bronwyn

Cite this

@article{ed92327100f0413885ae7a1fd7eb5be9,

title = "Targeting the PI3K Akt signaling pathway in pancreatic \$\textbackslash{}beta\$-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes",

author = "Sheila Donnelly",

year = "2022",

month = jan,

day = "1",

language = "English (Ireland)",

volume = "14",

journal = "Journal of Diabetes",

number = "4",

}